{"schema_version":"1","generated_at":"2026-11-17T07:58:00.636Z","data_as_of":null,"url":"https://www.findmykol.com/kol/nadia-ashai","json_url":"https://www.findmykol.com/kol/nadia-ashai/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"nadia-ashai","name":"Nadia Ashai","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"MedStar Washington Hospital Center","institution_url":"https://www.findmykol.com/institution/medstar-washington-hospital-center","city":"Washington","state":"DC","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1356683759","orcid":"0000-0002-2952-6941","openalex":"A5045793143"},"summary":"Nadia Ashai is an Oncology physician affiliated with MedStar Washington Hospital Center. OpenAlex indexes 23 publications with 269 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":23,"cited_by_count":269,"h_index":6,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04720664","title":"Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Georgetown University","source_url":"https://clinicaltrials.gov/study/NCT04720664","trial_url":"https://www.findmykol.com/trial/NCT04720664"}],"source":"trials"},"payments":{"company_count":42,"program_years":{"first":2021,"last":null},"rows_total":51,"shown":3,"withheld":48,"rows":[{"payer":"Pfizer","program_year":2025,"amount_usd":6250,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356683759"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":864.8,"payment_count":19,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356683759"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":265.39,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356683759"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1356683759","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":94.3,"classes_total":3,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":75.2,"drugs":[{"name":"Letrozole","share_pct":63.6},{"name":"Anastrozole","share_pct":36.4}],"max_beneficiaries":39},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":11.3,"drugs":[{"name":"Kisqali","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":5.7,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":5.7,"drugs":[{"name":"Ondansetron Odt","share_pct":100}],"max_beneficiaries":11}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":6.5,"facility_pct":93.5},"source":"medicare"},"publications":{"total":23,"shown":5,"withheld":18,"matched_by":"OpenAlex author record","recent":[{"title":"Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022","year":2024,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1016/j.annonc.2024.07.245","status":"verified"},{"title":"Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study","year":2024,"journal":"npj Breast Cancer","source_url":"https://doi.org/10.1038/s41523-024-00692-w","status":"verified"},{"title":"Pharmacokinetics (PK) and pharmacogenomics (PGx) of ribociclib (ribo) in Black patients with metastatic breast cancer (mBC): The LEANORA study.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.1581","status":"verified"},{"title":"Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study","year":2024,"journal":"Research Square","source_url":"https://doi.org/10.21203/rs.3.rs-4656461/v1","status":"verified"},{"title":"9354 Combination Of Novel Ruthenium-based Small Molecule Bold-100 And Capecitabine Is Effective In Inhibiting Growth Of Estrogen Receptor Positive Metastatic Breast Cancer","year":2024,"journal":"Journal of the Endocrine Society","source_url":"https://doi.org/10.1210/jendso/bvae163.2231","status":"verified"}],"source":"works"},"contact":{"address_1":"3800 RESERVOIR RD NW","city":"Washington","state":"DC","zip":"200072113","phone":"202-444-2223","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1356683759","source":"identity"},"similar":[{"name":"Augusto Pichard","slug":"augusto-pichard","institution":"MedStar Washington Hospital Center","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/augusto-pichard","json_url":"https://www.findmykol.com/kol/augusto-pichard/profile.json"},{"name":"Ron Waksman","slug":"ron-waksman","institution":"MedStar Washington Hospital Center","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/ron-waksman","json_url":"https://www.findmykol.com/kol/ron-waksman/profile.json"},{"name":"Lowell Satler","slug":"lowell-satler","institution":"MedStar Washington Hospital Center","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/lowell-satler","json_url":"https://www.findmykol.com/kol/lowell-satler/profile.json"},{"name":"Thomas Macgillivray","slug":"thomas-macgillivray","institution":"MedStar Washington Hospital Center","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/thomas-macgillivray","json_url":"https://www.findmykol.com/kol/thomas-macgillivray/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":48,"publications":18}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-03-20","provider_certified":"2024-03-20","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}